Social Media Ideas for Novo Nordisk

Novo Nordisk Flags Patient Data Breach From Some Clinical Trials in Cyberattack

Novo Nordisk said on Thursday it has identified a security incident in which certain information, including patient data from some clinical trials, was copied externally without au...

Novo Nordisk India rolls-out once-weekly basal insulin Awiqli

The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)

Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical

As Novo Nordisk looks for new ways to broaden its semaglutide GLP-1 franchise, the Danish drugmaker has signed a new deal with Californian medtech Vivani Medical to help.

CVS obesity drug deal puts Lilly on equal footing with Novo

The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk. 

<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]&g...

Novo Nordisk: Why I Don't Think The Story Is Broken

Novo Nordisk Launches Awiqli, World’s First Weekly Basal Insulin In India

Novo Nordisk has launched Awiqli (insulin icodec), the world’s first once-weekly basal insulin, in India. The company says the therapy could reduce the injection burden from 365 to...

Management

Management Anonymous (not verified) Mon, 06/29/2026 - 03:04 field_thread_url https://cafepharma.com/boards/threads/management.710052/ bo...

Management

Management Anonymous (not verified) Sun, 07/05/2026 - 06:08 field_thread_url https://cafepharma.com/boards/threads/management.710052/ bo...

Shantha Biologics to provide cartridge fill-finish services for Novo Nordisk

3 Reasons to Buy Novo Nordisk Stock

The stock is down, but it isn't out yet.

Novo hemorrhaging employees

Novo hemorrhaging employees Anonymous (not verified) Tue, 07/14/2026 - 12:15 field_thread_url https://cafepharma.com/boards/threads/novo-hemorrhaging-emplo...

Novo Nordisk launches higher-dose Wegovy for those seeking greater weightloss

Plans to file with the Indian regulator too, seeking approvals for the higher dose

EDE Welcomes Novo Nordisk’s Decision To Establish UAE Pharmaceutical Distribution Hub

Novo Nordisk, the global pharmaceutical company and a leader in developing treatments for diabetes, obesity and rare diseases, has announced the establishment of a regional distrib...

11 biotech companies leading the way in Denmark

Explore Denmark's dynamic biotech scene with 10 innovative companies at the forefront of the biopharmaceutical revolution! The post 11 biotech companies leading the way in Denmark...

Ozempic maker Novo Nordisk hit with $25 million ransom demand after claimed data breach

FulcrumSec says it spent more than two months inside Novo Nordisk's networks and is now exploring private sales of the data after the company refused to pay

Ozempic maker Novo Nordisk hit with $25 million ransom demand after claimed data breach

FulcrumSec says it spent more than two months inside Novo Nordisk's networks and is now exploring private sales of the data after the company refused to pay

Weight-loss drugs from Lilly, Novo linked to stalling cancer: report

Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics

Ozempic and Wegovy, both produced by Novo Nordisk, currently cost hundreds of dollars a month, depending on the dosage dispensed, in some cases more than $450.

Hacking Group Claims Major Hack of Novo Nordisk and Attempted $25M Extortion

A cyber extortion group claimed on Tuesday to have stolen more than a terabyte of data from pharmaceutical giant Novo Nordisk and said it is exploring selling parts of the data aft...

Novo reports data breach, tells clinical trial patients to 'remain vigilant'

As cybersecurity threats have proliferated across industries in recent years, biopharma companies have emerged as prominent targets, with intellectual property, patient data and ot...

<![CDATA[Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics]]>

Ozempic maker Novo Nordisk breach exposed patients’ clinical trial data

Novo Nordisk said this security incident affected patient data, including health information and birth year

Wholesalers Say Novo Can't Duck GLP-1 Antitrust Suits

Drug buyers want a New York federal judge to preserve proposed class claims accusing Novo Nordisk of paying Teva to delay generic competition with its Victoza GLP-1 drug, arguing t...